Researchers distinguish subcutaneous from visceral fat stem cells using specific cell markers

February 20, 2014

Scientists from A*STAR's Singapore Bioimaging Consortium (SBIC) led in the discovery that two little-known fat cell markers have huge potential to assist researchers to further their understanding of fats. The discovery was recently published in prestigious science journal, Stem Cell Reports.

Adipose or fat cells are essential for proper body function. Yet, being too fat is detrimental to your health and raises risk of developing metabolic diseases like diabetes, heart disease and hypertension. With worldwide obesity nearly doubling since 1980, there is an urgent need for research into the science of diseases caused by obesity.

Fat stem cells are "young" cells that mature into fully functioning fat cells. The research team looked at two different fat stem cells types: found beneath the skin and visceral fat surrounding internal organs. The researchers are able for the first time to tell apart subcutaneous from visceral fat stem cells using specific cell markers.

The researchers looked at 240 different markers present on the surface of fat stem cells and discovered two markers called CD10 and CD200. An imaging technique called High-Content Screening (HCS) was used to spot these markers individually by latching them with florescence tags. What the scientists found was subcutaneous fat contained more CD10 signals while visceral fat exhibited more CD200. By using the different composition of CD10 and CD200 on fat stem cell surface, scientists can use these marking signatures to differentiate subcutaneous from visceral fat.

It is already known that subcutaneous fat and visceral fat have different capabilities at storing excess lipids. Subcutaneous fat cells are able to effectively store excess lipids and keep them from leaking into other organs. However, visceral fat is less efficient at storing fat resulting in excess lipids entering the blood and other organs. Abnormally high levels of free lipids circulating in the body lead to inflammation, high blood pressure, diabetes and coronary plaque formation - a major cause of heart attack and stroke. The researchers view the difference in fat cells' ability to store lipids as "high-quality" in subcutaneous fat and "low-quality" in visceral fat. Professor Shigeki Sugii who heads the study discovered another use of the CD10 and CD200 markers; that they can be used to predict the quality of fat cells. Studies done in culture dishes show that fat with high CD10 / low CD200 mature into high-quality fat cells, while with low CD10 / high CD200 mature into low-quality fat cells.

Prof Sugii who is also the lead scientist at SBIC's Fat Metabolism and Stem Cell Group said, "Markers CD10 and CD200 will be a useful tool for visualising stem cell populations of distinct adipose tissue. Scientists can now diagnose the quality of individual from healthy or diseased people."

It will be beneficial for human health if there were treatments available that could turn vicious, low-quality visceral fat into high-quality subcutaneous fat. Using the method developed by SBIC, identification of stem cell types and their quality can be performed within two or three days, compared to the current two weeks.  Prof Sugii's method paves the way for scientists to speed up their high-throughput drug screenings for potential drugs targets to treat metabolic diseases caused by .

Explore further: 'Beige' cells key to healthy fat

More information: "Identification of Specific Cell-Surface Markers of Adipose-Derived Stem Cells from Subcutaneous and Visceral Fat Depots." Wee Kiat Ong, Chuen Seng Tan, Kai Li Chan, Grace Gandi Goesantoso, Xin Hui Derryn Chan, Edmund Chan, Jocelyn Yin, Chia Rou Yeo, Chin Meng Khoo, Jimmy Bok Yan So, Asim Shabbir, Sue-Anne Toh, Weiping Han, Shigeki Sugii Stem Cell Reports, Volume 2, Issue 2, 171-179, 06. DOI: 10.1016/j.stemcr.2014.01.002

Related Stories

'Beige' cells key to healthy fat

January 17, 2014
"Beige fat" cells found in healthy subcutaneous fat in mice play a critical role in protecting the body from the disease risks of obesity, report researchers at Dana-Farber Cancer Institute, who say their study findings may ...

Newly discovered brown fat cells hold possibilities for treating diabetes, obesity

November 21, 2013
Obesity and diabetes have become a global epidemic leading to severe cardiovascular disease. Researchers at the University of Utah believe their recent identification of brown fat stem cells in adult humans may lead to new ...

Radiographic imaging exposes relationship between obesity and cancer

December 4, 2013
Researchers at the National Institute for Aging are working to improve understanding about obesity and cancer. A study, published today in the journal Applied Physiology, Nutrition, and Metabolism, is the first to use direct ...

Fat in organs and blood may increase risk of osteoporosis

July 16, 2013
Excess fat around the belly has recently been identified as a risk factor for bone loss. Now, a new study has determined that excess liver and muscle fat also may be detrimental to bone.

Reducing liver protein SIRT1 levels

January 22, 2014
A new study led by Boston University School of Medicine (BUSM) demonstrates that the abnormal metabolism linked to obesity could be regulated in part by the interaction of two metabolic regulators, called the NAD-dependent ...

Recommended for you

Engineered protein treatment found to reduce obesity in mice, rats and primates

October 19, 2017
(Medical Xpress)—A team of researchers with pharmaceutical company Amgen Inc. report that an engineered version of a protein naturally found in the body caused test mice, rats and cynomolgus monkeys to lose weight. In their ...

New procedure enables cultivation of human brain sections in the petri dish

October 19, 2017
Researchers at the University of Tübingen have become the first to keep human brain tissue alive outside the body for several weeks. The researchers, headed by Dr. Niklas Schwarz, Dr. Henner Koch and Dr. Thomas Wuttke at ...

Cancer drug found to offer promising results in treating sepsis in test mice

October 19, 2017
(Medical Xpress)—A combined team of researchers from China and the U.S. has found that a drug commonly used to treat lung cancer in humans offers a degree of protection against sepsis in test mice. In their paper published ...

Tracing cell death pathway points to drug targets for brain damage, kidney injury, asthma

October 19, 2017
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury and ...

Study reveals key molecular link in major cell growth pathway

October 19, 2017
A team of scientists led by Whitehead Institute has uncovered a surprising molecular link that connects how cells regulate growth with how they sense and make available the nutrients required for growth. Their work, which ...

Inflammation trains the skin to heal faster

October 18, 2017
Scars may fade, but the skin remembers. New research from The Rockefeller University reveals that wounds or other harmful, inflammation-provoking experiences impart long-lasting memories to stem cells residing in the skin, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.